Hcg and derivatives as matrix metalloproteases inhibitors

Details Hcg and derivatives as matrix metalloproteases inhibitors Hcg and derivatives as matrix metalloproteases inhibitors

A - Human Necessities

61

K

A61K 38/24 (2006.01) A61P 9/00 (2006.01) A61P 25/00 (2006.01) A61P 29/00 (2006.01)

Patent

CA 2262582

The use of hCG, hCG .beta.-subunit, as well as fragments and active derivatives thereof, or hCG .beta.-core in the preparation of a medicament for the prophylaxis and/or the treatment of pathologies requiring inhibition of the matrix metalloprotease (MMP) enzymatic activity.

L'invention concerne l'utilisation de hCG, de hCG beta -sous-unité, ainsi que de fragments et de dérivés actifs de ces derniers, ou de hCG beta -noyau dans la préparation d'un médicament destiné à la prophylaxie et/ou le traitement d'affections nécessitant l'inhibition de l'activité enzymatique de la métalloprotéase de matrice.

Affiliated with

Also associated with

Rating

Hcg and derivatives as matrix metalloproteases inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hcg and derivatives as matrix metalloproteases inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hcg and derivatives as matrix metalloproteases inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1670966